Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-24-022539

EVP, Head of International sold 2,551 shares at an average $50.80 ($129,597)

  • EVP, Head of International acquired 5,469 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mazabraud Yann EVP, Head of International 2024-02-09 Option exercise +3,438 7,265 D: show line 1 in the form
Mazabraud Yann EVP, Head of International 2024-02-11 Option exercise +2,031 9,296 D: show line 2 in the form
Mazabraud Yann EVP, Head of International 2024-02-12 Sale −1,594 $51.38 $81,900 7,702 D: show line 3 in the form
Mazabraud Yann EVP, Head of International 2024-02-13 Sale −957 $49.84 $47,697 6,745 D: show line 4 in the form
Open-market sales · 2,551 sh · avg $50.80 · $129,597

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Mazabraud Yann EVP, Head of International 2024-02-09 Option exercise · Restricted Stock Units −3,438 6,874 D: show line 5 in the form
Mazabraud Yann EVP, Head of International 2024-02-11 Option exercise · Restricted Stock Units −2,031 2,031 D: show line 6 in the form
Loading xslF345X05/tm246165-4_4seq1.xml…